Change of central venous oxygen saturation (ScvO2) before and after the arterio-venous fistula creation in non-septic patients with kidney failure

Change of central venous oxygen saturation (ScvO2) before and after the arterio-venous fistula creation in non-septic patients with kidney failure - Change of central venous oxygen saturation (ScvO2) before and after the arterio-venous fistula creation in non-septic patients with kidney failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012272

Enrollment

Registered

2013-11-12

Start date

2013-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patients with chronic renal failure who undergo hemodialysis using double lumen catheter inserted at the internal jugular vein 2) The patients with stable health condition except for renal failure 3) Patients who received sufficient explanation, understood it and gave written consent based on their free will, before participating in this study

Exclusion criteria

Exclusion criteria: 1) The patients undergoing hemodialysis using double lumen catheter placed in femoral vein 2) The patients who received a blood transfusion between the measurements of ScvO2 3) The patients who had a major change in dry weight between the measurements of ScvO2 4) The patients receiving oxygen therapy 5) The patients whose flow of arterio-venous shunt is too small to perform hemodialysis 6) The patients who has other diseases affecting the blood oxygenation level 7) The patients who were judged inappropriate by the principal investigator

Design outcomes

Primary

Measure	Time frame
1) The change of ScvO2 before and after the treatment 2) Blood flow in arterio-venous fistula 3) Cardiac output	—

Secondary

Measure	Time frame
1) Observation of the changes in ScvO2 until the first use of the arterio-venous fistula 2) Observation of the change in the blood flow of arterio-venous fistula until the first use of the arterio-venous fistula	—

Countries

Japan

Contacts

Public ContactTerumasa HAYASHI

Osaka General Medical Center Nephrology/Hypertension

kenkyusien@gh.opho.jp06-6692-1201

Outcome results